Earnings summaries and quarterly performance for Concentrix.
Executive leadership at Concentrix.
Board of directors at Concentrix.
Research analysts who have asked questions during Concentrix earnings calls.
Ruplu Bhattacharya
Bank of America
6 questions for CNXC
Also covers: ARW, AVT, CDW +13 more
Vincent Colicchio
Barrington Research Associates
6 questions for CNXC
Also covers: ASUR, BBSI, CLMB +9 more
David Koning
Robert W. Baird & Co.
5 questions for CNXC
Also covers: ACN, AVDX, CPAY +16 more
Divya Goyal
Scotiabank
4 questions for CNXC
Also covers: ALYAF, GIB, GLOB +2 more
Joseph Vafi
Canaccord Genuity - Global Capital Markets
4 questions for CNXC
Also covers: ADV, ALIT, ASGN +20 more
Luke Morrison
Canaccord Genuity Group Inc.
2 questions for CNXC
Also covers: CINT
Aisling Grueninger
Bank of America
1 question for CNXC
Luke Morison
Canaccord Genuity
1 question for CNXC
Oliver Davies
Redburn Atlantic
1 question for CNXC
Also covers: LGN, ROL, VSTS
Robert Bamberger
Robert W. Baird & Co.
1 question for CNXC
Also covers: G, TASK, WNS
Recent press releases and 8-K filings for CNXC.
Concentrix Reports Q3 2025 Results, Updates Full-Year Guidance
CNXC
Earnings
Guidance Update
New Projects/Investments
- Concentrix reported Q3 2025 revenue of approximately $2.48 billion, an increase of 2.6% year-on-year on a constant currency basis and 4% year-on-year as reported, exceeding guidance. However, non-GAAP operating income was $305 million, below guidance primarily due to excess capacity and accelerated transformation initiatives.
- For Q4 2025, the company expects revenue between $2.525 billion and $2.550 billion and non-GAAP operating income of $320 million to $330 million. Full-year 2025 non-GAAP EPS guidance was updated to $11.11 to $11.23 per share.
- Adjusted free cash flow for Q3 was $179 million, an increase of $44 million year-on-year, and the full-year guidance was raised to between $585 million and $610 million. The company returned $64 million to shareholders, including $42 million in share repurchases and an increased quarterly dividend of $0.36 per share.
- Concentrix highlighted strong market position and revenue momentum, with almost 40% of new wins including AI technology platforms. The company's capital allocation priorities for next year will be debt repayment, supporting the dividend, and the share repurchase program.
Sep 25, 2025, 9:00 PM
Concentrix Reports Strong Q3 2025 Results and Raises Full-Year Outlook
CNXC
Earnings
Guidance Update
Share Buyback
- Concentrix reported Q3 2025 revenue of $2,483.3 million, a 4.0% increase year-over-year, and diluted earnings per common share (EPS) of $1.34, up 436.0% from the prior year.
- The company raised its full-year fiscal 2025 revenue outlook to between $9.798 billion and $9.823 billion and projects non-GAAP EPS between $11.11 and $11.23.
- For Q4 2025, Concentrix expects reported revenue to range from $2.525 billion to $2.550 billion and non-GAAP EPS between $2.85 and $2.96.
- Concentrix increased its quarterly dividend to $0.36 per share and repurchased approximately 800,000 common shares for $42.2 million in Q3 2025. The company anticipates returning more than $240 million to shareholders in fiscal 2025.
Sep 25, 2025, 8:08 PM
Concentrix Corp Discusses Strong Bookings, AI Strategy, and Market Evolution
CNXC
Revenue Acceleration/Inflection
New Projects/Investments
M&A
- Concentrix Corp reported exceeding its revenue guide for the last quarter and expects strong momentum in bookings to drive modest organic acceleration in the second half of the year, leading to a raised revenue guide.
- The company's investments in AI tools, specifically the IX Hello and IX Hero suites, are on pace to be accretive to margins by the back half of the year and into fiscal 2026, contributing to overall margin optimism.
- Concentrix is seeing continued share gains through vendor consolidation, driven by its capabilities in deploying generative AI and its ability to offer multi-pillar, technology-led solutions that differentiate it from competitors.
- The integration of the WebHelp acquisition is essentially complete, and the company has successfully achieved its $120 million synergy target, strengthening its footprint in Europe and Latin America.
Aug 12, 2025, 6:00 PM
Concentrix Reports Q2 2025 Results and Raises Full Year Outlook
CNXC
Earnings
Guidance Update
Share Buyback
- Concentrix Corporation reported Q2 2025 revenue of $2,417.4 million, an increase of 1.5% year-on-year, exceeding its guidance.
- Non-GAAP diluted EPS for Q2 2025 was $2.70, up 0.4% from the prior year, while GAAP diluted EPS was $0.63.
- The company generated $200.3 million in adjusted free cash flow in Q2 2025 and anticipates $625 million to $650 million for the full fiscal year 2025.
- Concentrix raised its full year 2025 reported revenue guidance to between $9.720 billion and $9.815 billion, with non-GAAP EPS projected at $11.53 to $11.76.
- The company expects to return more than $240 million to shareholders in fiscal 2025 via share repurchases and dividends, having already repurchased $45.0 million in shares during Q2 2025.
Jun 26, 2025, 12:00 AM
Concentrix Corp Amends Credit Agreement for New Debt Facilities
CNXC
Debt Issuance
- Concentrix Corp entered into an Amendment and Restatement Agreement on April 11, 2025, amending its existing credit agreement with major lenders including Bank of America and JPMorgan Chase, to restructure its debt facilities.
- The new credit package comprises a New Term Loan Facility of up to $750 million, a 3-Year Delayed Draw Term Loan Facility of up to $250 million, a 5-Year Delayed Draw Term Loan Facility of up to $500 million, and a Revolving Credit Facility of $1.1 billion, with potential additional borrowing capacity of $500 million.
- Specific use of proceeds includes repaying a portion of outstanding term loans and funding general corporate purposes, while maturity dates range from September 30, 2028 for some facilities to April 11, 2030 for others, with the Continued Term Loan Facility due on December 27, 2026.
Apr 11, 2025, 12:00 AM
Concentrix Amends Corporate Governance Provisions
CNXC
- Amendment to Corporate Documents: Filed on March 25, 2025, Concentrix amended its Certificate of Incorporation and Bylaws, updating key governance provisions.
- Revised Special Meeting Rules: The amendments enable stockholders with at least 25% ownership to call special meetings, subject to strict documentation and procedural requirements.
- Effective Upon Filing: The governance updates, including detailed rules on meeting call, postponement, and cancellation, are effective immediately upon filing.
Mar 31, 2025, 12:00 AM
Concentrix Reports Q1 2025 Strong Results
CNXC
Earnings
Guidance Update
Revenue Acceleration/Inflection
- Revenue reached approximately $2.37 billion in Q1 2025 with improved margins, including a non‐GAAP operating income margin of 13.6%, demonstrating solid year-over-year performance.
- The company advanced its GenAI strategy by deploying its iX Hello suite at scale and benefiting from increased consolidation among top clients, underpinning its long-term growth plan.
- Management provided robust guidance for Q2 and full-year 2025, expecting continued revenue growth, margin expansion, and sequential improvements in cash flow.
Mar 26, 2025, 9:01 PM
Concentrix Reports Q1 2025 Financial Results
CNXC
Earnings
Dividends
Share Buyback
- Revenue declined slightly by 1.3% to $2,372.2 million, while operating income increased to $168.9 million, reflecting improved operational performance.
- Non-GAAP operating income reached $321.5 million and adjusted EBITDA was $374.2 million, indicating strong underlying profitability.
- The company announced a quarterly dividend of $0.33275 per share and repurchased approximately 550,000 shares at an average cost of $47.84 per share, underscoring its commitment to returning capital to shareholders.
Mar 26, 2025, 12:00 AM
Quarterly earnings call transcripts for Concentrix.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more